Chromos Molecular Systems, a small Canadian drug developer, says it is laying off about half of its 25 workers and is preparing to file for bankruptcy. In a statement released on Thursday, the company ...
Chromos Molecular Systems Inc. has announced that it has expanded the scope of its collaboration agreement with Pfizer. Under the expanded agreement, Chromos will use its ACE System to develop a cell ...
MUMBAI, July 19 (Reuters) - Drug maker Glenmark Pharmaceuticals Ltd. said on Thursday it bought two new biological entities from Canada's Chromos Molecular Systems Inc. to strengthen its biological ...
For Royal College of Art design students Chris Glaister, Afshin Mehin and Tomas Rosen, the problem with concrete is once you put it down you can’t change it, and people have to just get used to it. So ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. © 2025 American City Business Journals. All rights ...
Chromos Molecular Systems Inc. has signed a contract with AppTec Laboratory Services Inc. for scale-up and manufacture of its monoclonal antibody drug product candidate CHR-1103. Chromos has used its ...
No articles found. Chromos Molecular Systems Inc. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.
Genetic diseases might one day be treated by adding an entirely new chromosome to people’s cells. A Canadian company has shown the approach could be a feasible method of gene therapy. Conventional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback